Correlation Between Kezar Life and Karyopharm Therapeutics
Can any of the company-specific risk be diversified away by investing in both Kezar Life and Karyopharm Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kezar Life and Karyopharm Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kezar Life Sciences and Karyopharm Therapeutics, you can compare the effects of market volatilities on Kezar Life and Karyopharm Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kezar Life with a short position of Karyopharm Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kezar Life and Karyopharm Therapeutics.
Diversification Opportunities for Kezar Life and Karyopharm Therapeutics
0.75 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Kezar and Karyopharm is 0.75. Overlapping area represents the amount of risk that can be diversified away by holding Kezar Life Sciences and Karyopharm Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Karyopharm Therapeutics and Kezar Life is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kezar Life Sciences are associated (or correlated) with Karyopharm Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Karyopharm Therapeutics has no effect on the direction of Kezar Life i.e., Kezar Life and Karyopharm Therapeutics go up and down completely randomly.
Pair Corralation between Kezar Life and Karyopharm Therapeutics
Considering the 90-day investment horizon Kezar Life Sciences is expected to under-perform the Karyopharm Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Kezar Life Sciences is 1.88 times less risky than Karyopharm Therapeutics. The stock trades about -0.08 of its potential returns per unit of risk. The Karyopharm Therapeutics is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 82.00 in Karyopharm Therapeutics on August 25, 2024 and sell it today you would earn a total of 3.00 from holding Karyopharm Therapeutics or generate 3.66% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Kezar Life Sciences vs. Karyopharm Therapeutics
Performance |
| Timeline |
| Kezar Life Sciences |
| Karyopharm Therapeutics |
Kezar Life and Karyopharm Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Kezar Life and Karyopharm Therapeutics
The main advantage of trading using opposite Kezar Life and Karyopharm Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kezar Life position performs unexpectedly, Karyopharm Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Karyopharm Therapeutics will offset losses from the drop in Karyopharm Therapeutics' long position.| Kezar Life vs. Century Therapeutics | Kezar Life vs. Mineralys Therapeutics, Common | Kezar Life vs. Nkarta Inc | Kezar Life vs. Surrozen |
| Karyopharm Therapeutics vs. X4 Pharmaceuticals | Karyopharm Therapeutics vs. Hookipa Pharma | Karyopharm Therapeutics vs. Mereo BioPharma Group | Karyopharm Therapeutics vs. Acumen Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Complementary Tools
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |